MedPath

Kinesiotaping Versus Pilate Exercises

Not Applicable
Completed
Conditions
Exercise
Dysmenorrhea
Interventions
Other: kinesiotaping application
Other: Pilate exercises program
Registration Number
NCT04359381
Lead Sponsor
Cairo University
Brief Summary

Sixty girls participated in this study and their main complaints were pain and cramping during menstruation. They were divided randomly into two equal groups.

Detailed Description

Group (A) (30 girls) treated by kinesiotaping during menstruation for 3 successive menstruation. Group (B) (30 girls) treated by pilate exercises, 3 sessions per week for 3 months except the days of menstruation. Visual analogue scale to assess pain intensity, Quality of life enjoyment and satisfaction questionnaire, Menstrual Distress Questionnaire, WALIDD score, Spielberger questionnaire and blood sample analysis to estimate plasma prostaglandin level were applied for each girl in both groups before and after the treatment course.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Their ages ranged from 14 to 20 years old
  • their body mass index (BMI) would be less than 25 Kg/m2
  • having primary dysmenorrhoea
Exclusion Criteria
  • skin diseases or cardiac diseases
  • irregular or infrequent menstrual cycles
  • previous abdominal or back operations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
kinesiotapingkinesiotaping applicationby kinesiotaping during menstruation for 3 successive menstruation
pilate exercisesPilate exercises programpilate exercises, 3 sessions per week for 3 months
Primary Outcome Measures
NameTimeMethod
Weight and height scalethree months

Was used to measure the weight and height of each girl before starting the study and to calculate BMI according to the following formula: BMI = weight (kg) / height square (m)2

Secondary Outcome Measures
NameTimeMethod
Visual analog scalethree months

For determining pain intensity before and after the treatment course for each girl in both groups (A\&B). VAS is a-10 cms line, at one end was written (no pain = zero) and at the other end was written (worst pain the patient ever felt = 10)

Trial Locations

Locations (1)

Ghada Elrefaye

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath